Ulcerative Colitis (UC) Completed Phase 3 Trials for Tofacitinib (DB08895)

Also known as: UC - Ulcerative Colitis / Colitis, Ulcerative (UC) / Ulcerative Colitis / Colitis, Ulcerative / Colitis,Ulcerative / Colitis Ulcerative / Proctocolitis, idiopathic / Idiopathic proctocolitis / UC / Ulcerative colitis, unspecified

IndicationStatusPhase
DBCOND0052192 (Ulcerative Colitis (UC))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01458951A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative ColitisTreatment
NCT01458574A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative ColitisTreatment
NCT01465763A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative ColitisTreatment